Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?
about
Glycosylation of therapeutic proteins: an effective strategy to optimize efficacyUbiquitin fusion expression and tissue-dependent targeting of hG-CSF in transgenic tobacco.Clinical practice and future needs in recombinant human granulocyte colony-stimulating factor treatment: a review of randomized trials in clinical haemato-oncology.Expression of the functional recombinant human glycosyltransferase GalNAcT2 in Escherichia coliFully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected PeptidesLenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Rapid transient expression of human granulocyte-macrophage colony-stimulating factor in two industrial cultivars of tobacco (Nicotiana tabacum L.) by agroinfiltration.Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins.The significance of carbohydrates on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation.Recombinant Proteins and Monoclonal Antibodies.Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control.Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator ProductTransient co-expression with three -glycosylation enzymes allows production of GalNAc--glycosylated Granulocyte-Colony Stimulating Factor inImproving Immunotherapy Through Glycodesign
P2860
Q33586660-D82584AA-624C-4353-80C0-7430E2002F74Q34045484-03E3AADB-8C80-49E0-BF5F-E496BCBE293CQ34274265-26045086-6733-4435-A637-A56DFD8A6E93Q34987860-4DEFCFB1-C23C-4947-ACBE-7A0B71FBD933Q36198586-5DD3D669-AF4B-4769-852E-211CE2866A5FQ37866758-54C26E9C-46E6-4ED9-8742-F0DE179B66AFQ37996560-FBF2DF6E-83DB-44AE-AD24-19A4C0026AC1Q39001712-D4D178E8-BECC-43BC-9C62-2439E49BFE9AQ42572918-3F2BF476-46AD-48B6-8C77-AD60F18745DCQ44681169-70660B5A-CB61-4D42-B267-40F18118A701Q47602370-4B27A78F-37D3-4EF6-8395-C7045A6A4A5BQ53549083-A9AE2961-2D31-4F7D-B09D-783EBDFF73FFQ57049370-66CA0B39-04C4-4735-81E5-4EE7BF7CB69FQ58608473-1A5440EF-F10C-4ABD-9741-7690ADD60F9CQ59132146-AABA6E30-17E9-41F6-97BD-51ADCBE97B9B
P2860
Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Glycosylated and non-glycosyla ...... -CSF)--what is the difference?
@en
type
label
Glycosylated and non-glycosyla ...... -CSF)--what is the difference?
@en
prefLabel
Glycosylated and non-glycosyla ...... -CSF)--what is the difference?
@en
P356
P1433
P1476
Glycosylated and non-glycosyla ...... -CSF)--what is the difference?
@en
P2093
P2888
P304
P356
10.1007/BF02787205
P577
1998-12-01T00:00:00Z
P6179
1038340940